As senators prepare to face drug makers, these tough questions are top of mind

The 27 senators who sit on the Senate Finance Committee are set to grill seven drug company executives Tuesday morning about high prescription drug prices. STAT spoke with lawmakers in both parties about what they plan to ask, what they hope to hear, and what answers they won’t accept. Below are five major takeaways.